Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of the Intensity of Cellular and Humoral Immunity to COVID-19 Causative Agent in Moscow Residents

NCT04898140 is registered in ClinicalTrials.gov with Moscow Department of Health as lead sponsor.

NCT NCT04898140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of the Intensity of Cellular and Humoral Immunity to COVID-19 Causative Agent in Moscow Residents
Lead sponsor
Moscow Department of Health
Phase
Observational
Overall status
Completed
Start date
October 20, 2020
Completion date
December 31, 2021
Enrollment
5,340 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, respiratory viral infection